Cargando…
Are Patients With Autoimmune Disease at Greater Risk of Developing Severe COVID-19?
Autores principales: | Lagadinou, Maria, Zareifopoulos, Nicholas, Karela, Anastasia, Kyriakopoulou, Ourania, Velissaris, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430874/ https://www.ncbi.nlm.nih.gov/pubmed/32849942 http://dx.doi.org/10.14740/jocmr4245 |
Ejemplares similares
-
Neuropsychiatric Effects of Antiviral Drugs
por: Zareifopoulos, Nicholas, et al.
Publicado: (2020) -
Correlation of Positive Blood Cultures with Peripherally Inserted Central Catheter Line Infection in Oncology Patients
por: Platanaki, Christina, et al.
Publicado: (2021) -
Hypersensitivity coronary myocardial infarction (Kounis syndrome) and COVID-19 vaccines
por: Kounis, Nicholas G., et al.
Publicado: (2022) -
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022) -
Rare Hypersensitivity Myocardial Reactions Following COVID-19 Vaccination: Hypersensitivity Myocardial Infarction (Kounis Syndrome) and Hypersensitivity Myocarditis
por: Kounis, Nicholas G., et al.
Publicado: (2022)